HIV vaccine
US7067134B1 · kind B1 · utility
9Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 12, 1999 |
| Grant date | Jun 27, 2006 |
| Priority date | — |
| Expiry date | Aug 12, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel HIV vaccine is provided. In particular, the vaccine comprises an avirulent and non-cytolytic recombinant HIV wherein the NSS of the virus' envelope glycoprotein is replaced with a non-cytolytic signal sequence and nef gene of the virus is deleted which renders the virus avirulent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.